Showing results (11-20 of 49) with videos related to
Sort By:
Pageof 5
BJS Open|July 22, 2021
Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastasesJ Kjaer, P Stålberg, J Crona, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model SummitJohn Valgus, Kristin W Weitzel, Josh F Peterson, et al.Journal of Pharmacy Practice|March 22, 2014
The Value of Pharmacy Residency Training for Health Systems: An Annotated BibliographyJoshua T Swan, Mary Giouroukakis, Brandon R Shank, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 9, 2021
Tolerability of palbociclib in younger and older patients with advanced breast cancerTaylor Dennison, Hillary Heiling, Allison Deal, et al.Journal of Nephrology|November 14, 2018
Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapyMonica L Reynolds, Patrick H Nachman, Micah J Mooberry, et al.Bioorganic & Medicinal Chemistry Letters|August 6, 2019
Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolinesChristopher R M Asquith, Neil Fleck, Chad D Torrice, et al.The Oncologist|April 26, 2017
A Systematic Review of Strategies to Prevent Cisplatin-Induced NephrotoxicityDaniel J Crona, Aimee Faso, Tomohiro F Nishijima, et al.Neuroscience|March 21, 2007
Small interfering RNA-mediated selective knockdown of Na(V)1.8 tetrodotoxin-resistant sodium channel reverses mechanical allodynia in neuropathic ratsX-W Dong, S Goregoaker, H Engler, et al.Journal of Internal Medicine|December 12, 2018
Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paragangliomaA Muth, J Crona, O Gimm, et al.Clinical Pharmacology and Therapeutics|May 9, 2022
Polygenic Risk Scores for Blood Pressure to Assess the Risk of Severe Bevacizumab-Induced Hypertension in Cancer Patients (Alliance)Julia C F Quintanilha, Amy S Etheridge, Brady J Graynor, et al.Pageof 5